<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02318511</url>
  </required_header>
  <id_info>
    <org_study_id>RD2014-10-04</org_study_id>
    <nct_id>NCT02318511</nct_id>
  </id_info>
  <brief_title>An Investigation of ReNu™ Knee Injection in Patients With Osteoarthritis</brief_title>
  <official_title>An Investigation of ReNu™ Knee Injection: Monitoring the Response of Knee Function and Pain in Patients With Osteoarthritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NuTech Medical, Inc</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Organogenesis</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>NuTech Medical, Inc</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a Prospective, Randomized study evaluating the efficacy of ReNu for the treatment of&#xD;
      Kellgren-Lawrence grade 2 or 3 osteoarthritis. Patients will be randomized into 1 of 3 groups&#xD;
      for injection into the effected knee: 1) ReNu - study treatment, 2) Hyaluronic Acid (HA)&#xD;
      injection - with commonly used injection material and 3) Saline. After treatment, patients&#xD;
      will be followed up to 12 months to evaluate improvements using common pain and function&#xD;
      subscales.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2015</start_date>
  <completion_date type="Actual">February 2019</completion_date>
  <primary_completion_date type="Actual">January 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>VAS Pain Scale Change from Baseline</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>VAS Pain Scale Change from Baseline</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>KOOS Pain and Function Subscales Change from Baseline</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>KOOS Pain and Function Subscales Change from Baseline</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>KOOS Pain and Function Subscales change from Baseline</measure>
    <time_frame>1 week, 6 weeks, 3 months, and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Other patient reported outcomes (PROs) change from Baseline</measure>
    <time_frame>1 week, 6 week, 3 months, 6 months, and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiographic (X-ray) measurement of standing joint space change from Baseline</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">200</enrollment>
  <condition>Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>ReNu amniotic allograft</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Knee injection with ReNu. ReNu is an allograft tissue composed of particularized amniotic membrane and cell from the amniotic fluid.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Knee injection with saline. Injectable saline will be used as the placebo control.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HA injection</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Knee injection with HA. HA will be used as a viscosupplementation injection consisting of cross linked HA.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Knee injection</intervention_name>
    <description>Injection into knee for the treatment of Osteoarthritis</description>
    <arm_group_label>HA injection</arm_group_label>
    <arm_group_label>ReNu amniotic allograft</arm_group_label>
    <arm_group_label>Saline</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ReNu amniotic allograft</intervention_name>
    <arm_group_label>ReNu amniotic allograft</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>placebo saline</intervention_name>
    <arm_group_label>Saline</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hyaluronic Acid</intervention_name>
    <arm_group_label>HA injection</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with moderate knee osteoarthritis determined by a combination of clinical and&#xD;
             radiographic findings and documented by Kellgren-Lawrence radiographic classification&#xD;
             (Grade 2 or 3)&#xD;
&#xD;
          -  Grade 2 Kellgren-Lawrence radiographic changes are defined as small osteophytes,&#xD;
             possible narrowing of joint space&#xD;
&#xD;
          -  Grade 3 Kellgren-Lawrence radiographic changes are defined as moderate multiple&#xD;
             osteophytes, definite narrowing of joints space, some sclerosis and possible deformity&#xD;
             of bone contour.&#xD;
&#xD;
          -  Patients with bilateral grade 2 or 3 Kellgren Lawrence knee osteoarthritis who have&#xD;
             bilateral symptoms may have their more symptomatic knee injected. If equivalent&#xD;
             symptoms are reported by the patient, then the patient will choose which knee is to be&#xD;
             injected. The contralateral knee can be treated with local standard of care such as&#xD;
             steroid injection, cold therapy or soft brace.&#xD;
&#xD;
          -  Age 18 and older&#xD;
&#xD;
          -  BMI less than 40&#xD;
&#xD;
          -  7 day average pain score of 4 or greater for the involved knee on a numeric pain scale&#xD;
             from 1 to 10.&#xD;
&#xD;
          -  Female patients must be actively practicing a contraception method, abstinence, be&#xD;
             surgically sterilized, or be postmenopausal&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pain medication (including nonsteroidal antiinflammatory drugs, NSAIDs) less than 15&#xD;
             days before injection (may take acetaminophen)&#xD;
&#xD;
          -  Receiving pain medication other than acetaminophen for conditions unrelated to&#xD;
             osteoarthritis of the index knee&#xD;
&#xD;
          -  Regular use of anticoagulants, such as Coumadin, dabigatran or rivaroxaban; use of&#xD;
             antiplatelet medications are not a reason for exclusion&#xD;
&#xD;
          -  History of substance abuse.&#xD;
&#xD;
          -  Failure to agree NOT to take additional knee symptom modifying drugs, other than&#xD;
             acetaminophen, during the course of the study without reporting to the study team&#xD;
&#xD;
          -  Pregnancy or desire to become pregnant during study duration&#xD;
&#xD;
          -  Positive pregnancy test on premenopausal subject&#xD;
&#xD;
          -  Morbid obesity (defined as BMI 40 or greater)&#xD;
&#xD;
          -  Symptoms of locking, intermittent block to range of motion or loose body sensation&#xD;
             which could indicate meniscal displacement or an intraarticular loose body&#xD;
&#xD;
          -  Corticosteroid injection into the index knee within 3 months&#xD;
&#xD;
          -  Viscosupplement injection into the index knee within 3 months&#xD;
&#xD;
          -  Knee surgery of involved index knee within 12 months&#xD;
&#xD;
          -  Knee surgery contralateral knee 6 months&#xD;
&#xD;
          -  Worker compensation&#xD;
&#xD;
          -  Acute index knee injury (injury within 3 months)&#xD;
&#xD;
          -  History of Diabetes mellitus&#xD;
&#xD;
          -  History of solid organ or hematologic transplantation&#xD;
&#xD;
          -  History of rheumatoid arthritis or other autoimmune disorder&#xD;
&#xD;
          -  Diagnosis of a non-basal cell malignancy within the preceding 5 years&#xD;
&#xD;
          -  Infection requiring antibiotic treatment within the preceding 3 months&#xD;
&#xD;
          -  Current therapy with any immunosuppressive medication, including corticosteroids at a&#xD;
             dose &gt; 5 mg per day&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jack Farr, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>OrthoIndy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>American Sports Medicine Institute</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cedars-Sinai Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Midwest Orthopedics at Rush, LLC</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Orthoindy</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Center for Clinical and Translational Science UK Chandler Medical Center, Pavilion H</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40536-2093</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Chestnut Hill</city>
        <state>Massachusetts</state>
        <zip>02467</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Missouri Orthopaedic Institute (MOI)</name>
      <address>
        <city>Columbia</city>
        <state>Missouri</state>
        <zip>65212</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New Mexico Orthopaedics</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New York University</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10003</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital for Special Surgery</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43221</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Advanced Orthopedics</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23294</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>December 9, 2014</study_first_submitted>
  <study_first_submitted_qc>December 16, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 17, 2014</study_first_posted>
  <last_update_submitted>January 14, 2020</last_update_submitted>
  <last_update_submitted_qc>January 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyaluronic Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

